Operating Income for Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's current operating income (TTM) is $25.48B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$25.48B
YoY change
+15.6%
5Y CAGR
+5.3%
Peak year (2025)
$25.60B
Cumulative operating income
$486.04B
Operating Income history chart for Johnson & Johnson (JNJ) from 1985 to 2025
Operating Income history table for Johnson & Johnson (JNJ) from 1985 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $25.60B | +15.6% | ||
| 2024 | $22.15B | -5.4% | ||
| 2023 | $23.41B | +11.4% | ||
| 2022 | $21.01B | +0.3% | ||
| 2021 | $20.94B | +6.1% | ||
| 2020 | $19.73B | -5.9% | ||
| 2019 | $20.97B | -1.0% | ||
| 2018 | $21.18B | +12.1% | ||
| 2017 | $18.90B | -9.5% | ||
| 2016 | $20.89B | +14.2% | ||
| 2015 | $18.29B | -13.5% | ||
| 2014 | $21.14B | +11.5% | ||
| 2013 | $18.96B | +11.3% | ||
| 2012 | $17.03B | +5.4% | ||
| 2011 | $16.15B | -2.3% | ||
| 2010 | $16.53B | -0.8% | ||
| 2009 | $16.66B | +3.1% | ||
| 2008 | $16.17B | +6.3% | ||
| 2007 | $15.21B | +11.0% | ||
| 2006 | $13.71B | +6.8% | ||
| 2005 | $12.83B | +3.8% | ||
| 2004 | $12.36B | +13.7% | ||
| 2003 | $10.87B | +12.3% | ||
| 2002 | $9.68B | +22.7% | ||
| 2001 | $7.88B | +19.2% | ||
| 2000 | $6.62B | +10.5% | ||
| 1999 | $5.99B | +19.0% | ||
| 1998 | $5.03B | +8.8% | ||
| 1997 | $4.62B | +7.4% | ||
| 1996 | $4.30B | +22.6% | ||
| 1995 | $3.51B | +25.1% | ||
| 1994 | $2.81B | +17.3% | ||
| 1993 | $2.39B | +5.1% | ||
| 1992 | $2.28B | +5.2% | ||
| 1991 | $2.16B | +8.6% | ||
| 1990 | $1.99B | +19.9% | ||
| 1989 | $1.66B | +18.3% | ||
| 1988 | $1.40B | +16.1% | ||
| 1987 | $1.21B | +22.9% | ||
| 1986 | $983.60M | +17.1% | ||
| 1985 | $840.00M | — |
Operating Income values are taken from Johnson & Johnson's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Johnson & Johnson (JNJ) operating income totalled $25.60B – grew 15.6% year-over-year.
Johnson & Johnson operating income has recorded the values shown across consecutive periods, with a +5.3% compound annual growth rate over 2020–2025 (5 years).
The dataset's maximum operating income sits at $25.60B (2025); the minimum reading of $840.00M dates to 1985.
Within Healthcare, Johnson & Johnson (JNJ) ranks 4th among 8 peers we track. The peer median for operating income is $19.53B.
Johnson & Johnson Operating Income by Year
Johnson & Johnson Operating Income 2025: $25.60B
Johnson & Johnson operating income in 2025 was $25.60B, grew 15.6% from 2024. This figure represents the highest annual value in the available history.
Johnson & Johnson Operating Income 2024: $22.15B
Johnson & Johnson operating income in 2024 was $22.15B, declined 5.4% below 2023.
Johnson & Johnson Operating Income 2023: $23.41B
Johnson & Johnson operating income in 2023 was $23.41B, grew 11.4% from 2022.
Johnson & Johnson Operating Income 2022: $21.01B
Johnson & Johnson operating income in 2022 was $21.01B, edged up 0.3% from 2021.
Johnson & Johnson Operating Income 2021: $20.94B
Johnson & Johnson operating income in 2021 was $20.94B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers — Operating Income
Companies in the same sector as Johnson & Johnson, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $8.11B | Healthcare |
Frequently asked questions
What is Johnson & Johnson's operating income?
- Latest reported operating income for Johnson & Johnson (JNJ) is $25.48B (period ending March 31, 2026).
How has Johnson & Johnson operating income changed year-over-year?
- Johnson & Johnson (JNJ) operating income changed +15.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Johnson & Johnson operating income?
- Johnson & Johnson (JNJ) operating income compound annual growth rate is +5.3% over the most recent 5 years available.
When did Johnson & Johnson operating income hit its highest annual value?
- Johnson & Johnson operating income reached its highest annual value of $25.60B in 2025.
What was Johnson & Johnson operating income in 2024?
- Johnson & Johnson (JNJ) operating income in 2024 was $22.15B.
What was Johnson & Johnson operating income in 2025?
- Johnson & Johnson (JNJ) operating income in 2025 was $25.60B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
JNJ Overview
Company profile, financial tools, and key metrics
JNJ Revenue Counter
Earns $3,066 every second. See per minute, hour, and day.
JNJ Earnings Counter
Earns $657.60 per second net profit. See per minute, hour, and day.
JNJ Economic Scale
Exceeds Costa Rica's GDP. Compare with world economies.
JNJ What If Invested
What if you had invested $1,000? See historical returns from any date.
JNJ How It Makes Money
Discover visual breakdown of $96.68B in revenue — where it comes from and where it goes.
JNJ Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
JNJ Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
JNJ Daily Price Character
Steady · 47.0% historical win rate (green days). Streaks & record days.
JNJ Buybacks
1.00% TTM buyback yield. Shareholder yield & SBC comparison.
JNJ Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
JNJ Dividend Profile
Yield: 2.29%. Safety: 6/8. See full history.
JNJ Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
JNJ Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.